Gene Expression in High-risk Breast and Ovarian Cancer Patients
Germline mutations in human BRCA 1 and BRCA2 genes confer a lifetime risk of breast cancer of between 60 and 85% and a lifetime risk of ovarian cancer of between 15 and 40%. Identification of mutations in these genes either in healthy carriers or in those who have already developed cancer is importa...
Main Author: | Brazil, Lucy Caroline Alexandra |
---|---|
Published: |
Institute of Cancer Research (University Of London)
2008
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.504783 |
Similar Items
-
The role of endothelins in ovarian and breast cancer
by: Moraitis, Stavros
Published: (1997) -
WWOX, tumour suppressor and modifier gene, as a regulator of gene expression and apoptosis in ovarian cancer
by: Janczar, Szymon Lech
Published: (2010) -
Molecular and cellular expression of novel genes associated with breast cancer
by: Laversin, Stephanie Anne Sophie
Published: (2009) -
The putative oncogene EEF1A2 and its role in breast and ovarian cancer
by: Tomlinson, Victoria
Published: (2007) -
Tumour suppressor and anti-metastatic gene expression in human breast cancer : an immunohistochemical study
by: Sawan, Ali Sadek
Published: (1993)